MATERIALS AND METHODSReagents, enzymes, and DNA analysis. Antibiotics were purchased from Sigma Chemical Co., St. Louis, Mo., and were used at the following concentrations: tetracycline, 20 ,ug/ml for Escherichia coli and 10 ,ug/ml for Vibrio spp.; ampicillin, 80 ,ug/ml; chloramphenicol,20 ,ug/ml; kanamycin, 80 ,ug/ml. Restriction endonucleases were purchased from New England BioLabs, Inc., Boston, Mass. T4 DNA ligase was purchased from Bethesda Research Laboratories, Rockville, Md. Conditions for restriction and ligation of DNA followed the instructions of the manufacturer. ONPG (oto the arms of TnS-132 (pAl3105) was obtained from Alan Boyd, University of California, San Diego.Mutagenesis with Tn5. Transposon TnS-132 inserted into the genome of transducing phage P1 (P1 clrlOOCM) was obtained as a lysogen of E. coli C600 from D. Berg, Washington University. This transposon was constructed to encode tetracycline resistance in place of the wild-type kanamycin resistance (4, 16). Wild-type TnS could not be used, since Vibrio strains show considerable natural resistance to kanamycin. P1 lysates were prepared by temperature induction (5). The recipient bacterium, V. harveyi BB7 (from R. Belas, Agouron Institute), was grown in LM broth (10 g of tryptone [Difco], 5 g of yeast extract [Difco], and 20 g of NaCl per liter) to 5 x 108 cells per ml. CaCl2 was added to 25 mM, and P1 clrlOOCM::TnS-132 was added to a multiplicity of infection of 0.1. Cells were incubated at 30°C without shaking for 30 min to allow phage adsorption. The cell suspension was then diluted with 5 volumes of LM broth and incubated for 2 h at 30°C with shaking to permit expression of the tetracycline resistance phenotype. To select tetracy-on August 4, 2020 by guest